Combination of ZYBRESTAT With Bevacizumab Appears Well-Tolerated; Fewer Patient Deaths in Treatment Arm

Upcoming Milestones Include Presentation of Key Randomized Data in Phase 2 Study of ZYBRESTAT in Patients With Non-small Cell Lung Cancer

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5084006 for the full story.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5019559 for the full story.

SOUTH SAN FRANCISCO, CA - July 6, 2009 - OXiGENE, Inc. (Nasdaq:OXGN; Stockholm:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that the Company exercised its option to acquire all of the equity of Symphony ViDA, Inc. in exchange for six million newly-issued shares of OXiGENE common stock

Last weekend, in my Market Forecast, I wrote: "Although this rally looks to be struggling, I’m not necessarily convinced that it is done.  We are mostly in cash and will be prepared to trade on either side.  If the market indices break the support at the 30-day MA, we may see the slide accelerate.  SPX 875 [...]

RVSN Radvision Ltd 10.69
ROX Castle Brands Inc 2.11
PEIX Pacific Ethanol Inc 6.49
OXGN OXiGENE Inc 2.87
OSP Osg Amer L P 18.50
OCCF Optical Cable Corp 4.20
NSTK Nastech Pharmaceutical Co 4.98
IMOS Chipmos Tech Bermuda Ltd 5.08
III Information Services ... 7.00
IIG Imergent Inc 15.08
HOME Home Federal Bancorp Inc 12.43
HIA Highlands Acquisition ... 9.05
HFWA Heritage Finl Corp Wash 20.52
HBNC Horizon Bancorp Ind 25.00
EYE Advanced Medical Opti ... 24.58
EPIX Epix Pharmaceuticals Inc 3.33
EOF Merrill Lynch & Co Inc 9.31
ASFN Atlantic Southern Fin ... 23.17
ASBI Ameriana Bancorp 7.25
ARM Arvinmeritor Inc 12.49
ANS Airnet Sys Inc 2.01

 Subscribe in a reader

Astea International, Generex Biotechnology, NYSE Group, Applied Materials, Intuitive Surgical, Baidu.com